45 results
10-Q
2021 Q3
CGTX
Cognition Therapeutics Inc
17 Nov 21
Quarterly report
5:15pm
the continuing COVID-19 pandemic and measures taken to contain its spread ultimately impact our business, including our ongoing and future clinical trials … and to pursue our business objectives;
The COVID-19 pandemic may materially and adversely affect our business and our financial results and could cause
10-K
2021 FY
CGTX
Cognition Therapeutics Inc
30 Mar 22
Annual report
7:40am
and cash equivalents and the sufficiency of such resources to fund our planned operations;
the extent to which the COVID-19 pandemic and measures … funding;
our business has been and could continue to be adversely affected by the ongoing COVID-19 global pandemic and efforts to mitigate it in regions
S-1
61a7192cug
19 Jul 21
IPO registration
7:02am
DRS
464dkznun aioa
7 May 21
Draft registration statement
12:00am
424B4
7antld0ssq 7phjer2v
12 Oct 21
Prospectus supplement with pricing info
4:11pm
DRS/A
l80um7d ltnz
23 Jun 21
Draft registration statement (amended)
12:00am
8-K
EX-99.1
nmm6pj
11 May 22
Cognition Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
7:06am
8-K
EX-99.1
aqek qqef
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
8-K
EX-99.1
6d7xaz
2 Nov 23
Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
7:41am
8-K
EX-99.1
66d21 nttaj85j
7 May 24
Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update
7:39am